EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders

Emiliano Peña-Durán iD, Jesús Jonathan García-Galindo iD, Luis Daniel López-Murillo, Alfredo Huerta-Huerta iD, Luis Ricardo Balleza-Alejandri iD, Alberto Beltrán-Ramírez iD, Elsa Janneth Anaya-Ambriz iD, Daniel Osmar Suárez-Rico iD

International Journal of Molecular Sciences · 19.02.2025 · 26 (4) · 1773

DOI: 10.3390/ijms26041773 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.02.2025. Verfasst von Emiliano Peña-Durán und 7 weiteren Autor:innen. Beteiligte Einrichtung: Licenciatura en Médico Cirujano y Partero, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico. Hauptthemen laut MEDLINE: Biomarkers, Metabolic Diseases, Inflammation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human microbiota, a complex ecosystem of microorganisms, plays a pivotal role in regulating host immunity and metabolism. This review investigates the interplay between microbiota and inflammatory markers, emphasizing their impact on metabolic and autoimmune disorders. Key inflammatory biomarkers, such as C-reactive protein (CRP), interleukin-6 (IL-6), lipopolysaccharides (LPS), zonulin (ZO-1), and netrin-1 (Ntn1), are discussed in the context of intestinal barrier integrity and chronic inflammation. Dysbiosis, characterized by alterations in microbial composition and function, directly modulates the levels and activity of these biomarkers, exacerbating inflammatory responses and compromising epithelial barriers. The disruption of microbiota is further correlated with increased intestinal permeability and chronic inflammation, serving as a precursor to conditions like type 2 diabetes (T2D), obesity, and non-alcoholic fatty liver disease. Additionally, this review examines therapeutic strategies, including probiotics and prebiotics, designed to restore microbial balance, mitigate inflammation, and enhance metabolic homeostasis. Emerging evidence positions microbiota-targeted interventions as critical components in the advancement of precision medicine, offering promising avenues for diagnosing and treating inflammatory and metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMetabolic DiseasesInflammationGastrointestinal MicrobiomeMicrobiotaHumansAnimalsDysbiosisObesityProbiotics

Stichwörter der Autor:innen

biomarkerschronic diseasesdysbiosisinflammationinsulin resistancemicrobiotaprobiotics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Licenciatura en Médico Cirujano y Partero, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Calle Sierra Mojada 950, Independencia Oriente, Guadalajara 44340, Mexico.
  • Departamento Académico Aparatos y Sistemas II, Decanato de Ciencias de la Salud, Universidad Autónoma de Guadalajara, Zapopan 44670, Mexico.
  • Departamento Académico Aparatos y Sistemas I, Decanato de Ciencias de la Salud, Universidad Autónoma de Guadalajara, Zapopan 44670, Mexico.
  • Hospital Medica de la Ciudad, Santa Catalina, Calle. Pablo Valdez 719, La Perla, Guadalajara 44360, Mexico.
  • Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.

ORCID-Profile: Emiliano Peña-Durán, Jesús Jonathan García-Galindo, Alfredo Huerta-Huerta, Luis Ricardo Balleza-Alejandri, Alberto Beltrán-Ramírez, Elsa Janneth Anaya-Ambriz, Daniel Osmar Suárez-Rico

Zitieren

APA

Peña-Durán, E., García-Galindo, J. J., López-Murillo, L. D., Huerta-Huerta, A., Balleza-Alejandri, L. R., Beltrán-Ramírez, A., Anaya-Ambriz, E. J., & Suárez-Rico, D. O. (2025). Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders. International Journal of Molecular Sciences, 26(4), 1773. https://doi.org/10.3390/ijms26041773

Vancouver

Peña-Durán E, García-Galindo JJ, López-Murillo LD, Huerta-Huerta A, Balleza-Alejandri LR, Beltrán-Ramírez A, et al. Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders. International Journal of Molecular Sciences. 2025;26(4):1773. doi:10.3390/ijms26041773

BibTeX
@article{PeaDurn2025,
  author = {Peña-Durán, Emiliano and García-Galindo, Jesús Jonathan and López-Murillo, Luis Daniel and Huerta-Huerta, Alfredo and Balleza-Alejandri, Luis Ricardo and Beltrán-Ramírez, Alberto and Anaya-Ambriz, Elsa Janneth and Suárez-Rico, Daniel Osmar},
  title = {Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {1773},
  doi = {10.3390/ijms26041773}
}
Kostenlos starten →